The world’s political tectonic plates may be shifting, but this has done little to undermine the achievements of the pharma, biotech and allied industries over the past year, and last night we celebrated the best of these at the 12th annual Scrip Awards in London.
In a lavish ceremony presented by the broadcaster Jeremy Vine, most recently seen walking all over the BBC’s US election night virtual map, Scrip rewarded excellence across the whole range of business activities between June 2015 and May 2016.
2016 has proved to be an interesting year in many unexpected ways, creating uncertainty for our sector. But against a changing political backdrop, industry has continued to develop innovative new drugs, make strides in scientific research and forge new alliances. New investment continues to flow into biotech even as we grapple with pricing and the coming of age of biosimilars.
The Scrip Awards categories range from those that reward the broader achievements of companies, to those for innovation in deal making, advances in R&D and the more personal accomplishments of teams and individuals. New this year, we added the Community Partnership of the Year award to acknowledge the numerous ways in which pharma and biotech companies give back to the wider community.
Overall, Genmab was the big winner of the night, receiving two trophies, but the loudest applause went to this year’s Lifetime Achievement Award recipient, Dr. Raymond F. Schinazi.
See the full list of the 2016 Scrip Awards winners here: http://www.scripawards.com/2016-winners/